Concepedia

Holger Martinius

HM

Statistics

Publications

6

Citations

416

H-Index

6

Active since

2003

Affiliations

Neovii Biotech (Germany)(Current)

Medizinische Hochschule Hannover

Georg Speyer Haus

Holger Martinius is an author at Neovii Biotech (Germany) specializing in life sciences, antiviral therapy, and antiretroviral therapy.

Publications per year

2003–2015

6

Publications

6

Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides

Marc Egelhofer, Gunda Brandenburg, Holger Martinius et al. · Journal of Virology · 2003 · 146 citations · Full text

, , +17

Transfer of Autologous Gene-modified T Cells in HIV-infected Patients with Advanced Immunodeficiency and Drug-resistant Virus

Jan van Lunzen, Tobias Glaunsinger, Ingrid Stahmer et al. · Molecular Therapy · 2007 · 138 citations · Full text

, , +16

A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3

Morten Mau‐Sørensen, Christian Dittrich, Rodrigo Dienstmann et al. · Cancer Chemotherapy and Pharmacology · 2015 · 65 citations

, , +16

Sorption and biodegradation of 2,4-dichlorophenol in the presence of organoclays

Barbara Witthuhn, Peter Klauth, Erwin Klumpp et al. · Applied Clay Science · 2004 · 39 citations

, , +10

Protein Scaffold and Expression Level Determine Antiviral Activity of Membrane-Anchored Antiviral Peptides

Felix G. Hermann, Holger Martinius, Marc Egelhofer et al. · Human Gene Therapy · 2009 · 17 citations

, , +15

1–5 of 6